RESEARCH FIELD

Translational Medicine

Translational medicine accelerates the bidirectional flow of knowledge between basic biomedical research and clinical practice. Adaptive clinical trial designs respond to accumulating data by modifying randomization ratios, doses, or endpoints in real time, increasing efficiency and reducing patient exposure to inferior treatments. Patient-derived organoids replicate tumor drug sensitivity ex vivo to predict clinical response, informing personalized oncology decisions. Multi-omics biomarker panels stratify patient populations by molecular subtype, enabling responder-enriched trials that detect efficacy signals obscured in unselected populations. The COVID-19 pandemic demonstrated the potential for platform trial infrastructure to evaluate multiple therapies simultaneously, shortening development timelines from years to months when urgency demands it.